From a cardiovascular device innovation standpoint, the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston ...
October 11, 2018
October 4, 2018 — The Ohio State University Wexner Medical Center is first in the country to test a new medical device ...
October 04, 2018Sponsored Content
Blog | Artificial Intelligence
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 10, 2022
One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon ...
October 03, 2018
September 28, 2018 — Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical ...
September 28, 2018
William Abraham, M.D., FACC, professor of medicine and director of the division of cardiovascular medicine, The Ohio ...
September 26, 2018
September 26, 2018 — Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic ...
September 26, 2018
September 24, 2018 — Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early ...
September 24, 2018
September 20, 2018 — Cardiac Dimensions announced the company has randomized its first patient in the CARILLON Pivotal ...
September 20, 2018
September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival ...
September 07, 2018
September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart ...
September 06, 2018
August 13, 2018 — Congestive heart failure (CHF) is a terminal disease that affects nearly 6 million Americans. Yet its ...
August 13, 2018
August 7, 2018 — While heart failure is an uncommon complication of breast cancer treatment, the risk is higher in ...
August 07, 2018
July 17, 2018 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive ...
July 17, 2018
July 11, 2018 — French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave ...
July 11, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now